Literature DB >> 6425896

External stimulus control in a "drug-discrimination" procedure: drug effects and inter-animal variation.

W Koek, J L Slangen.   

Abstract

Rats (N = 12) were trained to discriminate between two stimulus conditions S1 and S2, consisting of combinations of visual and tactile stimuli [S1: box lighted (L) and wooden floor insert present (W); S2: box dark (D) and grid floor present (G)] in a two-lever discrimination procedure. S1 was continuously present during half of the sessions, and S2 was continuously present during the remaining sessions. Morphine (0.3--6 mg/kg) and haloperidol (0.04--0.08 mg/kg), but not chlorpromazine (1--4 mg/kg) and scopolamine (0.031--0.125 mg/kg), decreased the accuracy of discriminative responding during S1 sessions. None of the drugs significantly affected discrimination accuracy during S2 sessions. After drug testing was completed, reversed combinations of the visual and tactile stimuli were tested (i.e. L + G, and D + W). Inter-animal variation in the control by the component stimuli was observed. The results suggest that "intermediate results" (i.e. equal responding on drug and saline lever) in drug discrimination research, if observed at the highest dose of a drug at which animals still respond, may be interpreted in terms of a drug-induced disruption of discriminative responding. The results further suggest that inter-animal variation in the outcome of drug generalization tests may be partly related to inter-animal variation in the degree of stimulus control by different components of the training drug stimulus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425896     DOI: 10.1007/bf00427767

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  Attention in the pigeon.

Authors:  G S REYNOLDS
Journal:  J Exp Anal Behav       Date:  1961-07       Impact factor: 2.468

Review 2.  Discriminative stimulus properties of narcotic analgesic drugs.

Authors:  F C Colpaert
Journal:  Pharmacol Biochem Behav       Date:  1978-12       Impact factor: 3.533

3.  Classification of drugs according to their discriminable effects in rats.

Authors:  H Barry
Journal:  Fed Proc       Date:  1974-07

4.  The role of fentanyl training dose and of the alternative stimulus condition in drug generalization.

Authors:  W Koek; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  Effects of morphine and chlorpromazine on the detection of shock.

Authors:  M A Lloyd; J B Appel; W T McGowan
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

6.  An analysis of some perceptual effects of morphine, chlorpromazine, and LSD.

Authors:  L L Hernandez; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

7.  Interaction between discrimination of drug states and external stimuli.

Authors:  P M Duncan; J Phillips; J Reints; M D Schechter
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

8.  Effects of pentazocine and other opiates on shock detection in the rat: involvement of opiate and dopamine receptors.

Authors:  L L Hernández; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

9.  Drug effects on discrimination performance at two levels of stimulus control.

Authors:  C Ksir; B Slifer
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  9 in total
  2 in total

1.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure.

Authors:  J De Vry; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.